<%@ Page Title="" Language="C#" MasterPageFile="~/masterpages/moduleGerman.master" AutoEventWireup="true" CodeFile="references-sd.aspx.cs" Inherits="secure_modules_module1_references_sd" %>

<asp:Content ID="Content1" ContentPlaceHolderID="contentBreadcrumb" Runat="Server">
    Multiple Sklerose verstehen \ Alle Referenzen
</asp:Content>
<asp:Content ID="Content2" ContentPlaceHolderID="contentSideBar" Runat="Server">
</asp:Content>
<asp:Content ID="Content3" ContentPlaceHolderID="contentMain" Runat="Server">
     <div class="module1page">
        <h1>
            Alle Referenzen</h1>
            <div class="icon_reading">
        <ul class="references">
            <li><span>Hauser SL and Goodin SC. Multiple sclerosis and other demyelinating diseases. In
                Fauci AS, Braunwald E, Karger DL <i>et al.</i> Harrison’s Principles of Internal Medicine</i>.
                17th edition. New York, NY: McGraw-Hill Medical; 2008: Chapter 375.</span></li>
            <li><span>World Health Organisation and Multiple Sclerosis International Federation. Atlas
                Multiple Sclerosis Resources in the World 2008.</span></li>
            <li><span>Alonso A and Hernán MA. Temporal trends in the incidence of multiple sclerosis.
                A systematic review. <i>Neurology</i> 2008; 71(2):129–35.</span></li>
            <li><span>Pugliatti M, Rosati G, Carlton H, <i>et al</i>. The epidemiology of multiple sclerosis
                in Europe. <i>Eur J Neurol</i> 2006; 13(7): 700–22.</span></li>
            <li><span>Fleming JO and Carrithers MD. Diagnosis and management of multiple sclerosis: A
                handful of patience. <i>Neurology</i> 2010; 74(11): 876–7.</span></li>
            <li><span>Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple
                sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune
                encephalomyelitis research. <i>Brain</i> 2006; 129(Pt 8):1953–71.</span></li>
            <li><span>Kantarci O and Wingerchuck D. Epidemiology and natural history of multiple sclerosis:
                new insights. <i>Curr Opin Neurol</i> 2006; 19(3): 248–54.</span></li>
            <li><span>Coleman J, Rath L, Carey J. Multiple Sclerosis and the role of the MS nurse consultant.
                <i>Aust Nurs J</i> 2001; 9(3): Suppl. 1–4.</span></li>
            <li><span>Hopman WM, Coo H, Edgar CM, <i>et al</i>. Factors associated with health-related quality
                of life in multiple sclerosis. <i>Can J Neurol Sci</i> 2007; 34(2):160–66.</span></li>
            <li><span>Lalmohamed A, Bazelier MT, Van Staa TP, <i>et al</i>. Causes of death in patients with
                multiple sclerosis and matched referent subjects: A population-based cohort study.
                <i>Eur J Neurol</i> 2012; e pub ahead of print.</span></li>
            <li><span>GryttenTorkildsen N, Lie SA, Aarseth JH, <i>et al</i>. Survival and cause of death in MS:
                results from a 50-year follow-up in Western Norway. <i>Mult Scler</i> 2008; 14(9): 1191–8.</span></li>
            <li><span>Kingwell E, van de Kop M, Zhao Y, <i>et al</i>. Relative mortality and survival in multiple
                sclerosis: findings from British Columbia, Canada. <i>J Neurol Neurosurg Psychiatry</i>
                2012; 83(1): 61–6.</span></li>
            <li><span>Lublin FD and Reingold SC. Defining the clinical course of multiple sclerosis: results
                of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee
                on Clinical Trials of New Agents in Multiple Sclerosis. <i>Neurology</i> 1996; 46(4): 907–11.</span></li>
            <li><span>Murray TJ. Diagnosis and treatment of multiple sclerosis. <i>BMJ</i> 2006; 332(7540): 525–7.</span></li>
            <li><span>Compston A. The basis for treatment in multiple sclerosis. <i>Acta Neurol Scand Suppl</i>
                2006; 183: 41-7.</span></li>
            <li><span>Poser CM. Viking voyages: the origin of multiple sclerosis? An essay in medical
                history. <i>Acta Neurol Scand Suppl</i>. 1995; 161: 11-22.</span></li>
            <li><span>McAlpine D, Lumsden CE, Acheson ED (eds). <i>Multiple sclerosis: a re-appraisal</i>. Edinburgh;
                Churchill Livingstone; 1972: 543–48.</span></li>
            <li><span>Kurtzke JF. Epidemiology and etiology of multiple sclerosis. <i>Phys Med Rehabil Clin
                N Am</i> 2005; 16(2): 327-49.</span></li>
            <li><span>Kurtzke JF. The epidemiology of multiple sclerosis. In: <i>Multiple Sclerosis, Clinical
                and Pathogenic Basis</i>. Rainew CS, McFarland HF, Tourellotte WW, Eds. London: Chapman
                and Hall, 1997.</span></li>
            <li><span>Huang H, Hughes M, Mobley S, <i>et al</i>. APOE genotypes in African American female MS
                patients. <i>Neurosci Lett</i> 2007; 414(1): 51–6.</span></li>
            <li><span>Detels R, Visscher BR, Malmgren RM, <i>et al</i>. Evidence for lower susceptibility to
                MS in Japanese-Americans. <i>Am J Epidemiol</i> 1977; 105(4): 303–10.</span></li>
            <li><span>Absoud M, Cummins C, Chong WK, <i>et al</i>. Paediatric UK demyelinating disease longitudinal
                study (PUDDLS). BMC Pediatr 2011; 11: 68.</span></li>
            <li><span>Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I:
                the role of infection. <i>Ann Neurol</i> 2007; 61(4): 288–99.</span></li>
            <li><span>Willer CJ and Ebers GC. Susceptibility to multiple sclerosis: interplay between
                genes and environment. <i>Curr Opin Neurol</i> 2000: 13(3): 241–7.</span></li>
            <li><span>Barnes D. <i>Multiple sclerosis. Questions and answers</i>.UK Merit Publishing International;
                2000.</span></li>
            <li><span>Compston A and Coles A. Multiple sclerosis. <i>Lancet</i> 2002; 359(9313): 1221–31.</span></li>
            <li><span>Robertson NP, Fraser M, Deans J, <i>et al</i>. Age-adjusted recurrence risks for relatives
                of patients with multiple sclerosis. <i>Brain</i> 1996; 119(Pt 2): 449–55.</span></li>
            <li><span>de Jong BA, Huizinga TW, Zanelli E, <i>et al</i>. Evidence of additional genetic risk indicators
                of relapse-onset MS within the HLA region. <i>Neurology</i> 2002; 59(4): 549–55.</span></li>
            <li><span>Zuvich RL, McCauley JL, Pericak-Vance MA, <i>et al</i>. Genetics and Pathogenesis of Multiple
                Sclerosis. Semin Immunol 2009; 21(6): 328–33.</span></li>
            <li><span>Sadovnick AD, Armstrong H, Rice GP, <i>et al</i>. A population-based study of multiple
                sclerosis in twins: update. <i>Annals of Neurology</i> 1993; 33(3): 281–5.</span></li>
            <li><span>Bruder CE, Piotrowski A, Gijsber AA, <i>et al.</i> Phenotypically concordant and discordant 
                monozygotic twins diplay differnet DNA copy-number-variation profiles. <i>Am J Hum Genet</i> 2008; 
                82(3): 763-71.</span></li>
            <li><span>Baranzini SE, Mudge J, van Velkinburgh JC, <i>et al</i>. Genome, epigenome and RNA sequences
                of monozygotic twins discordant for multiple sclerosis. <i>Nature</i> 2010; 464(7293):
                1351–6.</span></li>
            <li><span>Willer CJ, Dyment DA, Risch NJ, <i>et al</i>. Twin concordance and sibling recurrence rates
                in multiple sclerosis. <i>Proc Natl Acad Sci</i> USA 2003; 100(22); 12877–82.</span></li>
            <li><span>Handunnetthi L, Handel AE, Ramagopalan SV. Contribution of genetic, epigenetic and
                transcriptomic differences to twin discordance in multiple sclerosis. <i>Expert Rev
                Neurother</i> 2010; 10(9): 1379–81.</span></li>
            <li><span>Goodin DS. The causal cascade to multiple sclerosis: a model for MS pathogenesis,
                <i>PLoS One</i> 2009; 4(2): e4565.</span></li>
            <li><span>Smolders J, Thewissen M, Peelen E, <i>et al</i>. Vitamin D status is positively correlated
                with regulatory T-cell function in patients with multiple sclerosis. <i>PLoS One</i> 2009;
                4(8): e6635.</span></li>
            <li><span>Cantorna MT. Vitamin D and multiple sclerosis: an update. <i>Nutr Rev</i> 2008; 66(10 Suppl
                2): S135–8.</span></li>
            <li><span>Golan D, Somer E, Dishon S, <i>et al</i>. Impact of exposure to war stress on exacerbations
                of multiple sclerosis. <i>Ann Neurol</i> 2008; 64(2): 143–8.</span></li>
            <li><span>Mikaeloff Y, Caridade G, Tardieu M <i>et al</i>. KIDSEP study group. Parental smoking at
                home and the risk of childhood-onset multiple sclerosis in children. <i>Brain</i> 2007;
                130(Pt 10): 2589–95.</span></li>
            <li><span>Zivadinov R, Weinstock-Guttman B, Hashmi K, <i>et al</i>. Smoking is associated with increased
                lesion volumes and brain atrophy in MS. <i>Neurology</i> 2009; 73(7): 504–10.</span></li>
            <li><span>Buljevac D, Flach HZ, Hop WC <i>et al</i>. Prospective study on the relationship between
                infections and multiple sclerosis exacerbations. <i>Brain</i> 2002; 125(Pt 5): 952–60.</span></li>
            <li><span>Kriesel JD, Sibley WA. The case for rhinoviruses in the pathogenesis of multiple
                sclerosis. Mult Scler 2005; 11(1):1–4.</span></li>
            <li><span>Murray J. Infection as a cause of multiple sclerosis. <i>BMJ</i> 2002; 325(7373): 1128.</span></li>
            <li><span>Bar-Or A. Immunology of multiple sclerosis. <i>Neurol Clin</i> 2005; 23(1): 149–75.</span></li>
            <li><span>Noseworthy JH, Lucchinetti C, Rodriguez M <i>et al</i>. Multiple sclerosis. <i>N Engl J Med</i>
                2000; 343(13): 938-52.</span></li>
            <li><span>Frohman EM, Racke MK, Raine CS. Multiple sclerosis – the plaque and its pathogenesis.
                <i>N Engl J Med</i> 2006; 354(9): 942–55.</span></li>
            <li><span>Fox RJ, Bethoux F, Goldman MD <i>et al</i>. Multiple sclerosis: Advances in understanding,
                diagnosing and treating the underlying disease. <i>Cleve Clin J Med</i> 2006; 73(1): 91–102.</span></li>
            <li><span>Confavreux C, Vukusic S, Moreau T <i>et al</i>. Relapses and progression of disability
                in multiple sclerosis. <i>N Engl J Med</i> 2000; 343(20): 1430–8.</span></li>
            <li><span>Frohman EM. Multiple sclerosis. <i>Med Clin North Am</i> 2003; 87(4): 867–97.</span></li>
            <li><span>Trapp BD, Petersen J, Ransohoff RM, <i>et al</i>, Axonal transaction in the lesions of
                multiple sclerosis. <i>N Engl J Med</i> 1998; 338(5): 278–85.</span></li>
            <li><span>Peterson LK, Fujinami RS. Inflammation, demyelination, neurodegeneration and neuroprotection
                in the pathogenesis of MS. <i>J Neuroimmunol</i> 2007; 184(1-2): 37–44.</span></li>
            <li><span>Filippi M, Bozzali M, Rovaris M, <i>et al</i>. Evidence for widespread axonal damage at
                the earliest clinical stage of multiple sclerosis. <i>Brain</i> 2003; 126(Pt 2): 433-7.</span></li>
            <li><span>Dhib-Jalbut S. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
                <i>Neurology</i> 2007; 68(22 Suppl 3): S13–21.</span></li>
            <li><span>Edwards JC, Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune
                diseases. <i>Nat Rev Immunol</i> 2006; 6(5): 394–403.</span></li>
            <li><span>Magliozzi R, Howell O, Vora A, <i>et al</i>. Meningeal B-cell follicles in secondary progressive
                multiple sclerosis associated with early onset of disease and severe cortical pathology.
                <i>Brain</i> 2007; 130(Pt 4); 1089–104.</span></li>
            <li><span>Uccelli A, Aloisi F, Pistoia V. Unveiling the enigma of the CNS at a B-cell fostering
                environment. <i>Trends Immunol</i> 2005; 26(5): 254¬–6.</span></li>
            <li><span>Flensner G, Ek A-C, Söderhamn O, <i>et al</i>. Sensitivity to heat in MS patients: a factor
                strongly influencing symptomology – an explorative survey. <i>BMC Neurol</i> 2011; 11:
                27.</span></li>
            <li><span>Syndulko K, Jafari M, Woldanski A, Baumhefner RW, Tourtellotte WW: Effects of Temperature
                in multiple sclerosis: a review of the literature. <i>Neurorehabil Neural Repair</i> 1996,
                10:23-34.</span></li>
            <li><span>Guthrie TC, Nelson DA. Influence of temperature changes on multiple sclerosis: critical
                review of mechanisms and research potential. <i>J Neurol Sci</i> 1995, 129(1): 1–8.</span></li>
            <li><span>Simmons RD, Ponsonby AL, van der Mei I, <i>et al</i>. What affects your MS? Responses to
                an anonymous, Internet-based epidemiological survey. <i>Mult Scler</i> 2004; 10(2): 202–11.</span></li>
            <li><span>Marino FE. Heat reactions in multiple sclerosis: An overlooked paradigm in the study
                of comparative fatigue. <i>Int J Hyperthermia</i> 2009; 25(1): 34-40.</span></li>
            <li><span>Baker DG. Multiple sclerosis and thermoregulatory dysfunction. <i>J Appl Physiol</i> 2002,
                92(5): 1779–80.</span></li>
            <li><span>Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. <i>Arch
                Phys Med Rehab</i> 1984; 65(3):135–8.</span></li>
            <li><span>Krupp LB, Alvarez LA, LaRocca NG, <i>et al</i>. Fatigue in multiple sclerosis. <i>Arch Neurol</i>
                1988; 45(4): 435–7.</span></li>
            <li><span>Lerdal A, Celius EG, Krupp L, <i>et al</i>. A prospective study of fatigue in Multiple
                Sclerosis. <i>Eur J Neurol</i> 2007; 14(12): 1338–43.</span></li>
            <li><span>Pellicano C, Gallo A, Li X, <i>et al</i>. Relationship of cortial atrophy to fatigue in
                patients with MS. <i>Arch Neurol</i> 2010; 67(4): 447–53.</span></li>
            <li><span>Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the
                impact of fatigue and depression. <i>J Neurol Sci</i> 2002; 205(1): 51–8.</span></li>
            <li><span>Tartaglia MC, Narayanan S, Arnold DL. Mental fatigue alters the pattern and increases
                the volume of cerebral activation required for a motor task in multiple sclerosis
                patients with fatigue. <i>Eur J Neurol</i> 2008; 15(4): 413–9.</span></li>
            <li><span>DeLuca J, Johnson SK, Natelson BH. Information processing efficiency in chronic
                fatigue syndrome and multiple sclerosis. <i>Arch Neurol</i> 1993; 50(3): 301–4.</span></li>
            <li><span>DeLuca J, Genova HM, Hillary FG, <i>et al</i>. Neural correlates of cognitive fatigue in
                multiple sclerosis using functional MRI. <i>J Neurol Sci</i> 2008; 270(1–2): 28–39.</span></li>
            <li><span>Ford H, Trigwell P, Johnson M. The nature of fatigue in multiple sclerosis. <i>J Psychosom
                Res</i> 1998; 45(1): 33–8.</span></li>
            <li><span>Chaudhuri A, Behan PO. Fatigue in neurological disorders. <i>Lancet</i> 2004; 363(9413):
                978–88.</span></li>
            <li><span>Chu ER and Chen CS. Optic neuritis - more than a loss of vision. <i>Aust Fam Physician</i>
                2009; 38(10) 789-93.</span></li>
            <li><span>Foroozan R, Buono LM, Savino PJ, <i>et al</i>. Acute demyelinating optic neuritis. <i>Curr
                Opin Ophthalmol</i> 2002; 13(6): 375–80.</span></li>
            <li><span>Balcer LJ. Clinical practice. Optic neuritis. <i>N Engl J Med</i> 2006; 354(12): 1273–80.</span></li>
            <li><span>Boomer JA, Siatkowski RM. Optic neuritis in adults and children. <i>Semin Ophthalmol</i>
                2003; 18(4): 174–80.</span></li>
            <li><span>Germann CA, Baumann MR, Hamzavi S. Ophthalmic diagnoses in the ED: Optic neuritis.
                <i>Am J Emerg Med</i> 2007; 25(7): 834–7.</span></li>
            <li><span>Fazzito MM, Jordy SS, Tilbery CP. Psychiatric disorders in multiple sclerosis patients.
                <i>Arq Neuropsiquiatr</i> 2009; 67(3a): 664–7.</span></li>
            <li><span>Feinstein A. Neuropsychiatric syndromes associated with multiple sclerosis. <i>J Neurol</i>
                2007; 254(Suppl 2): II73–6.</span></li>
            <li><span>Gudiene D, Burba B. Mental disorders and their relation to brain loca¬tion: diagnostic
                problems. <i>Medicina (Kaunas)</i> 2003; 39(2): 114–21.</span></li>
            <li><span>Reiss JP, Sam D, Sareen J. Psychosis in multiple sclerosis associated with left
                temporal lobe lesions on serial MRI scans. <i>J Clin Neurosci</i> 2006; 13(2): 282–4.</span></li>
            <li><span>Calabrese M, Agosta F, Rinaldi F, <i>et al</i>. Cortical lesions and atrophy associated
                with cognitive impairment in relapsing-remitting multiple sclerosis. <i>Arch Neurol</i>
                2009; 66(9): 1144–50.</span></li>
            <li><span>Wiesel PH, Norton C, Glickman S, <i>et al</i>. Pathophysiology and management of bowel
                dysfunction in multiple sclerosis. <i>Eur J Gastroenterol Hepatol</i> 2001; 13(4): 441–8.</span></li>
            <li><span>Nicholas R, Young C, and Friede T. Bladder symptoms in multiple sclerosis: a review
                of pathophysiology and management. <i>Expert Opin Drug Saf</i> 2010; 9(6): 905–15.
            </span></li>
        </ul>
        </div>
    </div>
</asp:Content>

